Saturday, August 29, 2015

Roth ups TearLab price target to $4

Roth ups TearLab price target to $4

August 7, 2015 by · Leave a Comment 

Tweet Roth Capital Partners has raised its price target for TearLab (NASDAQ:TEAR; TSX:TLB) to $4 from $3 after the company posted a 27% jump in second quarter revenue. The stock closed at $2.48 on Friday. “TearLab delivered one of its stronger quarters in some time as 2Q revenues notably beat our projection driven by an […]

TearLab Q2 revenue climbs 27%

TearLab Q2 revenue climbs 27%

August 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported net revenue of $6.3-million for the second quarter this year, up 27%, from $5-million a year ago. A total of 394 orders for TearLab systems were booked in the second quarter, of which 303 were under the company’s new Flex program and 28 were purchased outside of the U.S. […]

Doctors discuss importance of tear film osmolarity

Doctors discuss importance of tear film osmolarity

August 4, 2015 by · Leave a Comment 

Tweet In an Eyetube.net video segment of the CRST Journal Club (Cataract & Refractive Surgery Today), Dr. John Davidson, of Miramar Eye Specialists in Ventura County, CA, and Dr. Jay Pepose, of the Pepose Vision Institute in St. Louis, discuss the importance of optimizing the ocular surface prior to premium intraocular lens surgery. Dr. Pepose […]

TearLab names Wes Brazell as CFO

TearLab names Wes Brazell as CFO

July 6, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Wes Brazell as CFO, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the company’s relationships and interactions with the investment community. He  succeeds William Dumencu, who will continue to support the company in a consulting role until the end […]

TearLab posts 28% increase in Q1 revenue

TearLab posts 28% increase in Q1 revenue

May 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) reported first quarter net revenue of $5.4-million, up 28% from $4.2-million for the same period in 2014. A total of 261 orders for TearLab systems were booked in the first quarter. “We started 2015 with a fully staffed sales force, a better understanding of implementation, and, as evidenced by the continuing […]

TearLab 2014 revenue climbs 35%

TearLab 2014 revenue climbs 35%

March 12, 2015 by · Leave a Comment 

Tweet 2014 net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) totalled $19.7-million, up 35% from $14.6-million in 2013. “2014 was a building year for us, with our primary focus being on improving the integration of the TearLab Osmolarity test into the daily routines of our customers,” CEO, Elias Vamvakas, said in a statement. “Moving into 2015, with an […]

TearLab in $35-million loan agreement with CRG

TearLab in $35-million loan agreement with CRG

March 5, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a term loan agreement with CRG and certain of its affiliate funds, which provides TearLab with up to $35-million of available borrowing capacity. Under the accord, CRG is initially providing TearLab with $15-million. Up to $20-million of additional funding will be available to TearLab, at its option, through […]

TearLab, Dipexium and Joint in Feltl 2015 Top Idea List

TearLab, Dipexium and Joint in Feltl 2015 Top Idea List

January 5, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB), Dipexium Pharmaceuticals (NASDAQ:DPRX) and The Joint Corp. (NASDAQ:JYNT) were included in Feltl & Co.’s 2015 Top Idea List released today. Analyst Ben Haynor rates TearLab at “strong buy” with a price target of $5. The stock closed at $2.58 on Friday. TearLab has first-mover advantage in point-of-care diagnostics for dry eye […]

TearLab Q3 revenue up 24%

TearLab Q3 revenue up 24%

November 5, 2014 by · Leave a Comment 

Tweet Third quarter net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) totalled $5.2-million, up 24% from $4.2 million a year ago A net 118 TearLab Osmolarity systems were added to the company’s installed base in the third quarter. Of those, 50 systems were under the Masters Multi Unit Program, 21 were through its minimum use access programs, […]

Julie Speed joins TearLab as VP global marketing

Julie Speed joins TearLab as VP global marketing

October 6, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Julie Speed to its senior management team as VP of global marketing. Her mandate will be leading global marketing functions for the complete TearLab portfolio, including its internal diagnostics product line and the OcuHub platform. Ms. Speed joins TearLab after 15 years of at Alcon Laboratories, where her previous […]

Next Page »

Email Newsletters with Constant Contact
Google+